China Medical System -B (02171): Data from Saikai Ze, CT071 and CT0590 will be presented at the 2024 ASH Annual Meeting.

Zhitong Finance · Oct 17 08:02

Kehai Pharmaceutical-B (02171) announced that it will showcase Saicai Ze at the 66th American Society of Hematology Annual Meeting...

Wise Finance App News, Kehai Pharmaceutical-B (02171) announced that it will showcase Saikai Ze (Zevokiorunhei injection, product number: CT053, a self-targeting BCMA CAR-T product), CT071 (a self-targeting GPRC5D CAR-T cell candidate product), and CT0590 (a self-targeting BCMA allogeneic CAR-T cell candidate product) clinical data at the 66th American Society of Hematology Annual Meeting. Abstracts and further information will be released after November 5, 2024 Eastern Time.

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

科济药业-B(02171)：赛恺泽、CT071和CT0590的数据将于2024年ASH年会上展示

China Medical System -B (02171): Data from Saikai Ze, CT071 and CT0590 will be presented at the 2024 ASH Annual Meeting.

Risk Disclaimer

Statement